Publication November 12, 2026

Exenatide Study Published in Pharmacological Research

A new scientific publication referencing exenatide was published on November 12, 2026. The paper, titled "Sympathetic neuroeffector remodeling and cardiomyocyte ferroptosis in heart failure: A stage- and compartment-specific framework for β-adrenergic/cAMP signaling," appeared in the journal Pharmacological Research.

The publication is indexed under PubMed ID 43020397. No findings, outcomes, or conclusions from the paper are included in this report beyond its title, journal, and publication date.

This brief reports only that the publication exists and where it was released. It does not characterize or summarize any results, data, or efficacy claims associated with the study. Readers interested in the full content of the research should consult the original source directly.

Exenatide remains an approved compound. This item documents the appearance of this publication in the scientific literature and does not imply any new regulatory action, safety finding, or clinical recommendation related to exenatide.

For background on exenatide, including its approved uses and general profile, readers can consult the compound overview.

See the full exenatide overview

Source: https://pubmed.ncbi.nlm.nih.gov/43020397/